home.aspx
 
. https://www.technologynetworks.com/tn/articles/the-value-and-versatility-of-clinical-flow-cytometry-327089
blog article
SHARESHARESHARE
THE VALUE AND VERSATILITY OF CLINICAL FLOW CYTOMETRY
The first conventional fluorescence-based flow cytometer was developed and commercialized in the late ‘60s/early ’70s in Germany.2 Over the last five decades, FCM has developed rapidly in terms of the number of its applications and the quantity and dimensionality of the data it generates.1,3 Dr. Minh Doan, formerly of the Imaging Platform of the Broad Institute (USA) and now head of Bioimaging Analytics at GlaxoSmithKline in the USA, states, “There have been significant advances in all three V’s of flow cytometry data: velocity (throughput/speed of data acquisition), volume (data content), and variety (sample types and signal acquisition technology).” NATASHA BEETON-KEMPEN READ MORE